Cerevel Therapeutics Hldng I shares owned by UBS Group
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $14M | 320k | 42.40 |
| 2023-09-30 | $4.0M | 183k | 21.83 |
| 2023-06-30 | $5.0M | 157k | 31.79 |
| 2023-03-31 | $4.4M | 179k | 24.39 |
| 2022-12-31 | $5.2M | 165k | 31.55 |
| 2022-09-30 | $539k | 19k | 28.25 |
| 2022-06-30 | $1.4M | 52k | 26.94 |
| 2022-03-31 | $1.3M | 37k | 34.36 |
| 2021-12-31 | $6.8M | 211k | 32.40 |
| 2021-09-30 | $243k | 8.2k | 29.53 |
| 2021-06-30 | $167k | 6.5k | 25.69 |
| 2021-03-31 | $115k | 8.4k | 13.69 |
| 2020-12-31 | $222k | 13k | 16.62 |